205 related articles for article (PubMed ID: 23350736)
1. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study.
Bonberg N; Pesch B; Behrens T; Johnen G; Taeger D; Gawrych K; Schwentner C; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Oberlinner C; Stenzl A; Brüning T
BMC Cancer; 2014 Nov; 14():854. PubMed ID: 25412927
[TBL] [Abstract][Full Text] [Related]
3. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
[TBL] [Abstract][Full Text] [Related]
5. Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC).
Matsuyama H; Ikemoto K; Eguchi S; Oga A; Kawauchi S; Yamamoto Y; Kawai Y; Matsumoto H; Hara T; Nagao K; Sakano S; Sasaki K
BJU Int; 2014 Apr; 113(4):662-7. PubMed ID: 23890221
[TBL] [Abstract][Full Text] [Related]
6. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
[TBL] [Abstract][Full Text] [Related]
7. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?
Bollmann M; Heller H; Bánkfalvi A; Griefingholt H; Bollmann R
BJU Int; 2005 Jun; 95(9):1219-25. PubMed ID: 15892805
[TBL] [Abstract][Full Text] [Related]
8. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
Krüger S; Mess F; Böhle A; Feller AC
Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
[TBL] [Abstract][Full Text] [Related]
9. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
[TBL] [Abstract][Full Text] [Related]
10. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer detection using FISH (UroVysion assay).
Halling KC; Kipp BR
Adv Anat Pathol; 2008 Sep; 15(5):279-86. PubMed ID: 18724101
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder cancer.
Gofrit ON; Zorn KC; Silvestre J; Shalhav AL; Zagaja GP; Msezane LP; Steinberg GD
Urol Oncol; 2008; 26(3):246-9. PubMed ID: 18452813
[TBL] [Abstract][Full Text] [Related]
13. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
14. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology.
Tapia C; Glatz K; Obermann EC; Grilli B; Barascud A; Herzog M; Schönegg R; Savic S; Bubendorf L
Cancer Cytopathol; 2011 Dec; 119(6):404-10. PubMed ID: 21732550
[TBL] [Abstract][Full Text] [Related]
16. Early results of bladder-cancer screening in a high-risk population of heavy smokers.
Steiner H; Bergmeister M; Verdorfer I; Granig T; Mikuz G; Bartsch G; Stoehr B; Brunner A
BJU Int; 2008 Aug; 102(3):291-6. PubMed ID: 18336612
[TBL] [Abstract][Full Text] [Related]
17. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
19. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer.
Nguyen CT; Litt DB; Dolar SE; Ulchaker JC; Jones JS; Brainard JA
Urology; 2009 Feb; 73(2):347-50. PubMed ID: 19022486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
